The biological activity of bispecific trastuzumab/pertuzumab plant biosimilars may be drastically boosted by disulfiram increasing formaldehyde accumulation in cancer cells
出版年份 2019 全文链接
标题
The biological activity of bispecific trastuzumab/pertuzumab plant biosimilars may be drastically boosted by disulfiram increasing formaldehyde accumulation in cancer cells
作者
关键词
-
出版物
Scientific Reports
Volume 9, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-11-07
DOI
10.1038/s41598-019-52507-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Disulfiram and BKM120 in Combination with Chemotherapy Impede Tumor Progression and Delay Tumor Recurrence in Tumor Initiating Cell-Rich TNBC
- (2019) Ling Wu et al. Scientific Reports
- Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines
- (2019) Zhi Yang et al. BIOMEDICINE & PHARMACOTHERAPY
- Process of immunogenic cell death caused by disulfiram as the anti-colorectal cancer candidate
- (2019) Si-yuan You et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: Current knowledge, new research directions and therapeutic perspectives
- (2019) Claudio Vernieri et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Cryo-EM Structure of HER2-trastuzumab-pertuzumab complex
- (2019) Yue Hao et al. PLoS One
- Suppressing autophagy enhances disulfiram/copper-induced apoptosis in non-small cell lung cancer
- (2018) Xi Wu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Blocking distinct interactions between Glioblastoma cells and their tissue microenvironment: A novel multi-targeted therapeutic approach
- (2018) Melanie Mettang et al. Scientific Reports
- Structural and functional characterization of MBS301, an afucosylated bispecific anti-HER2 antibody
- (2018) Sijia Huang et al. mAbs
- Mechanisms Underlying the Action and Synergism of Trastuzumab and Pertuzumab in Targeting HER2-Positive Breast Cancer
- (2018) Babak Nami et al. Cancers
- Human Endogenous Formaldehyde as an Anticancer Metabolite: Its Oxidation Downregulation May Be a Means of Improving Therapy
- (2018) Yuri L. Dorokhov et al. BIOESSAYS
- Pertuzumab and breast cancer: another piece in the anti-HER2 puzzle
- (2017) Lorenzo Gerratana et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- The making of bispecific antibodies
- (2017) Ulrich Brinkmann et al. mAbs
- Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4
- (2017) Zdenek Skrott et al. NATURE
- Plant-Made Antibodies: Properties and Therapeutic Applications
- (2017) Tatiana V. Komarova et al. CURRENT MEDICINAL CHEMISTRY
- Transcriptome-wide identification of mRNAs and lincRNAs associated with trastuzumab-resistance in HER2-positive breast cancer
- (2016) Callie R. Merry et al. Oncotarget
- Targeting HER2 for the Treatment of Breast Cancer
- (2015) Mothaffar F. Rimawi et al. Annual Review of Medicine
- Disulfiram-induced cytotoxicity and endo-lysosomal sequestration of zinc in breast cancer cells
- (2015) Helen L. Wiggins et al. BIOCHEMICAL PHARMACOLOGY
- Alternative molecular formats and therapeutic applications for bispecific antibodies
- (2015) Christoph Spiess et al. MOLECULAR IMMUNOLOGY
- Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer
- (2015) Jennifer L. Allensworth et al. Molecular Oncology
- Metabolic Methanol: Molecular Pathways and Physiological Roles
- (2015) Yuri L. Dorokhov et al. PHYSIOLOGICAL REVIEWS
- HER2-directed therapy: current treatment options for HER2-positive breast cancer
- (2015) Shahid Ahmed et al. Breast Cancer
- A conceptually new treatment approach for relapsed glioblastoma: Coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care.
- (2015) Richard E. Kast et al. Oncotarget
- Inhibitory effect of Disulfiram/copper complex on non-small cell lung cancer cells
- (2014) Lincan Duan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Endogenous Methanol Regulates Mammalian Gene Activity
- (2014) Tatiana V. Komarova et al. PLoS One
- Pertuzumab for the treatment of human epidermal growth factor receptor type 2-positive metastatic breast cancer
- (2013) C. Chung et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Bispecific Antibody to ErbB2 Overcomes Trastuzumab Resistance through Comprehensive Blockade of ErbB2 Heterodimerization
- (2013) B. Li et al. CANCER RESEARCH
- In vitro study on cytotoxicity and intracellular formaldehyde concentration changes after exposure to formaldehyde and its derivatives
- (2013) YJ Ke et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- Recombinant antibody mixtures: Production strategies and cost considerations
- (2012) Søren K. Rasmussen et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- HER2-Associated Radioresistance of Breast Cancer Stem Cells Isolated from HER2-Negative Breast Cancer Cells
- (2012) N. Duru et al. CLINICAL CANCER RESEARCH
- Inhibition of protein–protein interaction of HER2–EGFR and HER2–HER3 by a rationally designed peptidomimetic
- (2012) Sashikanth Banappagari et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Disulfiram, and Disulfiram Derivatives as Novel Potential Anticancer Drugs Targeting the Ubiquitin Proteasome System in Both Preclinical and Clinical Studies
- (2011) F. R. Kona et al. CURRENT CANCER DRUG TARGETS
- Nonprofit drugs as the salvation of the world's healthcare systems: the case of Antabuse (disulfiram)
- (2011) Boris Cvek DRUG DISCOVERY TODAY
- Plant-Made Trastuzumab (Herceptin) Inhibits HER2/Neu+ Cell Proliferation and Retards Tumor Growth
- (2011) Tatiana V. Komarova et al. PLoS One
- High Affinity Antigen Recognition of the Dual Specific Variants of Herceptin Is Entropy-Driven in Spite of Structural Plasticity
- (2011) Jenny Bostrom et al. PLoS One
- Transient expression systems for plant-derived biopharmaceuticals
- (2010) Tatiana V Komarova et al. Expert Review of Vaccines
- Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth
- (2010) Jianqing Lin et al. PROSTATE
- Disulfiram/copper complex inhibiting NFκB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines
- (2009) Xiaoxia Guo et al. CANCER LETTERS
- Strongly Enhanced Antitumor Activity of Trastuzumab and Pertuzumab Combination Treatment on HER2-Positive Human Xenograft Tumor Models
- (2009) W. Scheuer et al. CANCER RESEARCH
- Resistance to Trastuzumab in Breast Cancer
- (2009) P. R. Pohlmann et al. CLINICAL CANCER RESEARCH
- High-Throughput Cell-Based Screening of 4910 Known Drugs and Drug-like Small Molecules Identifies Disulfiram as an Inhibitor of Prostate Cancer Cell Growth
- (2009) K. Iljin et al. CLINICAL CANCER RESEARCH
- Differential binding of human immunoagents and Herceptin to the ErbB2 receptor
- (2008) Fulvia Troise et al. FEBS Journal
- HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion
- (2008) H Korkaya et al. ONCOGENE
- Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure
- (2008) Richard Strasser et al. PLANT BIOTECHNOLOGY JOURNAL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now